Left Ventricular Hypertrophy

• FDA approval · 2022-07-14
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for Losartan Potassium by Camber Pharmaceuticals, enabling the marketing of a generic Losartan P…

• FDA approval · 2019-07-05
  FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

  FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for Losartan Potassium Tablets, 25 mg, under ANDA201170.

• FDA approval · 2019-05-07
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)

  Supplemental application for Losartan Potassium from Micro Labs Limited has been approved by the FDA.

• FDA approval · 2016-11-16
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for Losartan Potassium, marking an approval of changes to the generic pr…

• FDA approval · 2016-06-10
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)

  The FDA approved a supplemental application for losartan potassium submitted by Alembic Pharmaceuticals Limited (ANDA 090428). This action u…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-06-10
  FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

  FDA approved Jubilant Cadista Pharmaceuticals Inc. to market Losartan potassium tablets, 25 mg, as a generic product under an ANDA supplemen…

• FDA approval · 2016-06-09
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Losartan Potassium (generic) from Lupin Pharmaceuticals, Inc.

• FDA approval · 2015-08-12
  FDA Approved: LOSARTAN POTASSIUM — Original Application (Camber Pharmaceuticals, Inc.)

  FDA approved Camber Pharmaceuticals' original generic application for losartan potassium, a generic version of the hypertension medication l…

• FDA approval · 2015-03-31
  FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

  FDA approved a supplemental application to add a 25 mg strength of Losartan Potassium Tablets, expanding the product's dosage options. The a…

• FDA approval · 2015-02-13
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)

  FDA approved a supplemental application for Losartan Potassium from Solco Healthcare US, LLC.

• FDA approval · 2014-12-11
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)

  The FDA approved a supplemental application for Losartan Potassium from Solco Healthcare US, LLC.

• FDA approval · 2014-09-25
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (AiPing Pharmaceutical, Inc.)

  FDA approved a supplemental application for Losartan Potassium from AiPing Pharmaceutical, Inc. under an ANDA, indicating an additional appr…

• FDA approval · 2013-06-10
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)

  FDA approved a supplemental application for losartan potassium by Alembic Pharmaceuticals Limited.

• FDA approval · 2013-01-28
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)

  FDA approves a supplemental application for Losartan Potassium from Macleods Pharmaceuticals Limited (ANDA202230), authorizing the generic p…

• FDA approval · 2012-12-20
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, resulting in approval of a generic losartan po…

• FDA approval · 2012-12-19
  FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)

  FDA approved the supplemental application for Losartan Potassium 25 mg by Strides Pharma Science Limited, authorizing the generic product fo…

• FDA approval · 2012-07-20
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  FDA approved a supplemental application for losartan potassium submitted by Quallent Pharmaceuticals Health LLC under ANDA078243.

• FDA approval · 2012-01-03
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  The FDA approved a supplemental application for losartan potassium from Quallent Pharmaceuticals Health LLC for an existing generic product.

• FDA approval · 2011-06-10
  FDA Approved: COZAAR — Supplemental Application (Organon LLC)

  The FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.

• FDA approval · 2011-06-06
  FDA Approved: LOSARTAN POTASSIUM — Original Application (Solco Healthcare US, LLC)

  The FDA approved Losartan Potassium as a generic product from Solco Healthcare US, LLC under original ANDA 091497.

• FDA approval · 2011-03-30
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)

  FDA approved a supplemental application for Losartan Potassium from Alembic Pharmaceuticals Limited, confirming approval of a generic produc…

• FDA approval · 2010-10-22
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  The FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.

• FDA approval · 2010-10-06
  FDA Approved: LOSARTAN POTASSIUM — Original Application (Alembic Pharmaceuticals Limited)

  FDA approved an original ANDA for Losartan Potassium from Alembic Pharmaceuticals Limited, enabling a generic version for hypertension and r…